nach oben

Current Anesthesiology Reports

Erschienen in:

23.03.2019 | Critical Care Anesthesia (BS Rasmussen, Section Editor)

Transfusion Requirements in Anesthesia and Intensive Care

Erschienen in: Current Anesthesiology Reports | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Allogeneic blood products are commonly used in perioperative and critically ill patients. This review focuses on the current evidence and emerging data relating to modern transfusion strategies in these patients.

Recent Findings

Several large randomized trials and meta-analyses found no inferiority of a restrictive strategy as compared to a liberal one in red blood cell (RBC) transfusion. The storage duration of transfused RBC seems to have a minor, if any, impact on patients’ outcome. However, patients requiring massive transfusions might be an exception. The indications and benefits of plasma and platelets transfusions are less clear because robust clinical evidence is missing.

Summary

In contrast to the established evidence and practice for RBC transfusion, the limited evidence for plasma and platelets transfusions call for incorporating expert opinions and guidelines and for standardized local practice. Targeted hemostatic interventions are preferred over prophylactic fixed-ratio transfusions in terms of efficacy and avoidance of transfusion-related complications.

Gilliss BM, Looney MR, Gropper MA. Reducing noninfectious risks of blood transfusion. Anesthesiology. 2011;115:635–49.PubMedPubMedCentral

•• Boer C, Meesters MI, Milojevic M, et al. EACTS/EACTA guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth. 2017;32:88–120 2018. Recent guidelines on patient blood management in cardiac surgery based on a systematic review. PubMed

Memtsoudis SG. Perioperative blood transfusions. BMJ. 2015;350:h3153.PubMed

Cannon JW. Hemorrhagic shock. N Engl J Med. 2018;378:370–9.PubMed

Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148:127–36.PubMedPubMedCentral

Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313:471–82.PubMedPubMedCentral

Sperry JL, Guyette FX, Brown JB, Yazer MH, Triulzi DJ, Early-Young BJ, et al. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med. 2018;379:315–26.PubMed

Cannon JW, Khan MA, Raja AS, et al. Damage control resuscitation in patients with severe traumatic hemorrhage: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2017;82:605–17.PubMed

Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123:615–24.PubMedPubMedCentral

10.

Ellermann I, Bueckmann A, Eveslage M, Buddendick H, Latal T, Niehoff D, et al. Treating anemia in the preanesthesia assessment clinic: results of a retrospective evaluation. Anesth Analg. 2018;127:1202–10.PubMed

11.

Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med. 2004;116(Suppl 7A):58S–69S.PubMed

12.

Shah A, Fisher SA, Wong H, Roy NB, McKechnie S, Doree C, et al. Safety and efficacy of iron therapy on reducing red blood cell transfusion requirements and treating anaemia in critically ill adults: a systematic review with meta-analysis and trial sequential analysis. J Crit Care. 2019;49:162–71.PubMed

13.

Russell L, Holst LB, Lange T, Liang X, Ostrowski SR, Perner A. Effects of anemia and blood transfusion on clot formation and platelet function in patients with septic shock: a substudy of the randomized TRISS trial. Transfusion. 2018;58:2807–18.PubMed

14.

Hare GM, Freedman J, David MC. Review article: risks of anemia and related management strategies: can perioperative blood management improve patient safety? Can J Anaesth. 2013;60:168–75.PubMed

15.

Karkouti K, Wijeysundera DN, Beattie WS. Reducing bleeding in cardiac surgery investigators. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation. 2008;117:478–84.PubMed

16.

Mazzeffi M, Chriss E, Tanaka K. Time for a fresh approach to examining factors associated with red blood cell transfusion outcome. Anesth Analg. 2018;127:1271–4.PubMed

17.

Agudelo-Jimenez RD, Heatter JA, Cata JP. Transfusion therapy: is there a link with cancer recurrence? Curr Anesthesiol Rep. 2018;8:426–38.

18.

• Carson JL, Triulzi DJ, Ness PM. Indications for and adverse effects of red-cell transfusion. N Engl J Med. 2017;377:1261–72 Recent excellent review on the risk of adverse events with RBC transfusion. PubMed

19.

Spitalnik SL. Stored red blood cell transfusions: iron, inflammation, immunity, and infection. Transfusion. 2014;54:2365–71.PubMedPubMedCentral

20.

Carson JL, Sieber F, Cook DR, Hoover DR, Noveck H, Chaitman BR, et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet. 2015;385:1183–9.PubMed

21.

Bolliger D, Mauermann E, Tanaka KA. Thresholds for perioperative administration of hemostatic blood components and coagulation factor concentrates: an unmet medical need. J Cardiothorac Vasc Anesth. 2015;29:768–76.PubMed

22.

•• Shehata N, Mistry N, da Costa BR, et al. Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis. Eur Heart J 2018;epub ahead. The largest meta-analysis on restrictive vs. liberal RBC transfusion in cardiac surgery.

23.

Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409–17.PubMed

24.

Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371:1381–91.PubMed

25.

Carson JL, Stanworth SJ, Alexander JH, Roubinian N, Fergusson DA, Triulzi DJ, et al. Clinical trials evaluating red blood cell transfusion thresholds: an updated systematic review and with additional focus on patients with cardiovascular disease. Am Heart J. 2018;200:96–101.PubMed

26.

Odutayo A, Desborough MJ, Trivella M, et al. Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials. Lancet Gastroenterol Hepatol. 2017;2:354–60.PubMed

27.

Carson JL, Brooks MM, Abbott JD, Chaitman B, Kelsey SF, Triulzi DJ, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J. 2013;165:964–71 e1.PubMedPubMedCentral

28.

Stokes EA, Wordsworth S, Bargo D, Pike K, Rogers CA, Brierley RCM, et al. Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial. BMJ Open. 2016;6:e011311.PubMedPubMedCentral

29.

Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Chan CT, Wong PY, et al. Advance targeted transfusion in anemic cardiac surgical patients for kidney protection: an unblinded randomized pilot clinical trial. Anesthesiology. 2012;116:613–21.PubMed

30.

Wang D, Sun J, Solomon SB, Klein HG, Natanson C. Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion. 2012;52:1184–95.PubMed

31.

Alexander PE, Barty R, Fei Y, Vandvik PO, Pai M, Siemieniuk RAC, et al. Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis. Blood. 2016;127:400–10.PubMed

32.

Heddle NM, Cook RJ, Arnold DM, Liu Y, Barty R, Crowther MA, et al. Effect of short-term vs. long-term blood storage on mortality after transfusion. N Engl J Med. 2016;375:1937–45.PubMed

33.

Cooper DJ, McQuilten ZK, Nichol A, et al. Age of red cells for transfusion and outcomes in critically ill adults. N Engl J Med. 2017;377:1858–67.PubMed

34.

•• McQuilten ZK, French CJ, Nichol A, Higgins A, Cooper DJ. Effect of age of red cells for transfusion on patient outcomes: a systematic review and meta-analysis. Transfus Med Rev. 2018;32:77–88 The most recent and largest review and meta-analysis regarding the effect of RBC storage duration on patients' outcome. PubMed

35.

Jones AR, Patel RP, Marques MB, et al. Older blood is associated with increased mortality and adverse events in massively transfused trauma patients: secondary analysis of the PROPPR trial. Ann Emerg Med 2018; epub ahead.

36.

Heddle NM, Arnold DM, Acker JP, Liu Y, Barty RL, Eikelboom JW, et al. Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort study. Lancet Haematol. 2016;3:e246–54.PubMed

37.

Valeri CR, Cassidy G, Pivacek LE, Ragno G, Lieberthal W, Crowley JP, et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion. 2001;41:977–83.PubMed

38.

Carson JL, Stanworth SJ. Anemia and bleeding in thrombocytopenic patients. Blood. 2017;130:1178–9.PubMed

39.

Uhl L, Assmann SF, Hamza TH, Harrison RW, Gernsheimer T, Slichter SJ. Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial. Blood. 2017;130:1247–58.PubMedPubMedCentral

40.

Ho CH. The hemostatic effect of packed red cell transfusion in patients with anemia. Transfusion. 1998;38:1011–4.PubMed

41.

Laine A, Niemi T, Schramko A. Transfusion threshold of hemoglobin 80 g/L is comparable to 100 g/L in terms of bleeding in cardiac surgery: a prospective randomized study. J Cardiothorac Vasc Anesth. 2018;32:131–9.PubMed

42.

Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA. 2016;316:2025–35.PubMed

43.

• Kozek-Langenecker S, Sorensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care. 2011;15:R239 An interesting review and meta-analysis on the effectiveness of plasma transfusion to improve hemostasis. PubMedPubMedCentral

44.

Haas T, Fries D, Tanaka KA, Asmis L, Curry NS, Schochl H. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br J Anaesth. 2015;114:217–24.PubMed

45.

Green L, Bolton-Maggs P, Beattie C, Cardigan R, Kallis Y, Stanworth SJ, et al. British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding. Br J Haematol. 2018;181:54–67.PubMed

46.

Abuelkasem E, Tanaka KA, Planinsic RM. Recent update on coagulation management and hemostatic therapies in liver transplantation. Minerva Anestesiol. 2018;84:1070–80.PubMed

47.

• Bolliger D, Tanaka KA. Coagulation management in cardiac surgery. Curr Anesthesiol Rep. 2017;7:265–72 A recent narrative review on current strategies of coagulation management in cardiac surgery.

48.

Chowdary P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol. 2004;125:69–73.PubMed

49.

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. Lancet. 2015;385:2077–87.PubMedPubMedCentral

50.

Bolliger D, Gorlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology. 2010;113:1205–19.PubMed

51.

Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, et al. Evidence-based practice guidelines for plasma transfusion. Transfusion. 2010;50:1227–39.PubMed

52.

Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth. 2012;108:384–94.PubMed

53.

Siegemund M, Scheuzger J, Holliger A, Gebhard C, Bolliger D. The value of crystalloid and colloidal volume substituion in patients with septic and haemorrhagic schick with respect to the microcirculation. Swiss Med Wkly. 2019;149:w20007 epub ahead.PubMed

54.

Bolliger D, Szlam F, Levy JH, Molinaro RJ, Tanaka KA. Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. Br J Anaesth. 2010;104:318–25.PubMed

55.

Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg. 2011;112:1289–95.PubMedPubMedCentral

56.

Chang R, Holcomb JB. Choice of fluid therapy in the initial management of sepsis, severe sepsis, and septic shock. Shock. 2016;46:17–26.PubMedPubMedCentral

57.

Chen L, Bracey AW, Radovancevic R, Cooper JR Jr, Collard CD, Vaughn WK, et al. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2004;128:425–31.PubMed

58.

Drews S, Bolliger D, Kaiser C, et al. Prasugrel increases the need for platelet transfusions and surgical reexploration rates compared with clopidogrel in coronary artery bypass surgery. Thorac Cardiovasc Surg. 2015;63:28–35.PubMed

59.

Avidan MS, Alcock EL, Da Fonseca J, et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth. 2004;92:178–86.PubMed

60.

Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162:205–13.PubMed

61.

Working Party of the Association of Anaesthetists of Great Britain & Ireland and the Obstetric Anaesthetists' Association Regional Anaesthesia UK. Regional anaesthesia and patients with abnormalities of coagulation. Anaesthesia. 2013;68:966–72.

62.

de Vries R, Haas F. Working group for revision of the Dutch Blood Transfusion Guideline 2011. English translation of the dutch blood transfusion guideline 2011. Clin Chem. 2012;58:1266–7.

63.

Baharoglu MI, Cordonnier C, Al-Shahi Salman R, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet. 2016;387:2605–13.PubMed

64.

Leong LB, David TK. Is platelet transfusion effective in patients taking antiplatelet agents who suffer an intracranial hemorrhage? J Emerg Med. 2015;49:561–72.PubMed

65.

Martin AC, Berndt C, Calmette L, Philip I, Decouture B, Gaussem P, et al. The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: an in-vitro study. Eur J Anaesthesiol. 2016;33:361–7.PubMed

66.

Bertling A, Fender AC, Schungel L, et al. Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelor. J Thromb Haemost. 2018;16:1089–98.PubMed

67.

Vuilliomenet T, Gebhard C, Bizzozero C, et al. Discontinuation of dual antiplatelet therapy and bleeding in intensive care in patients undergoing urgent coronary artery bypass grafting: a retrospective analysis. Interact Cardiovasc Thorac Surg 2018;epub ahead.

68.

Zafar MU, Smith DA, Baber U, et al. Impact of timing on the functional recovery achieved with platelet supplementation after treatment with ticagrelor. Circ Cardiovasc Interv. 2017;10:e005120.PubMedPubMedCentral

69.

•• Myles PS, Smith JA, Forbes A, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med. 2017;376:136–48 The largest RCT on the effectiveness of tranexamic acid on transfusion requriments after coronary artery surgery. PubMed

70.

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, et al. Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. JAMA Surg. 2013;148:538–47.PubMed

71.

Deloge E, Amour J, Provenchere S, Rozec B, Scherrer B, Ouattara A. Aprotinin vs. tranexamic acid in isolated coronary artery bypass surgery: a multicentre observational study. Eur J Anaesthesiol. 2017;34:280–7.PubMed

72.

Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING study. J Am Coll Cardiol. 2005;46:1820–6.PubMed

73.

Mahla E, Suarez TA, Bliden KP, et al. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv. 2012;5:261–9.PubMed

74.

Ranucci M, Baryshnikova E, Soro G, Ballotta A, de Benedetti D, Conti D. Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg. 2011;91:123–9.PubMed

75.

Coelho MJ, Monteiro Tde C, Vasquez FG, et al. Platelet aggregation and quality control of platelet concentrates produced in the Amazon Blood Bank. Rev Bras Hematol Hemoter. 2011;33:110–4.PubMedPubMedCentral

76.

• Althoff FC, Neb H, Herrmann E, et al. Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. Ann Surg 2018;epub ahead.A recent meta-analysis on the effectiveness of PBM programs in patients scheduled for elective surgery.

77.

Silliman CC, Fung YL, Ball JB, Khan SY. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev. 2009;23:245–55.PubMedPubMedCentral

78.

Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119:1757–67.PubMedPubMedCentral

79.

Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation. 2007;116:471–9.PubMed

80.

Loor G, Rajeswaran J, Li L, Sabik JF III, Blackstone EH, McCrae KR, et al. The least of 3 evils: exposure to red blood cell transfusion, anemia, or both? J Thorac Cardiovasc Surg. 2013;146:1480–7.PubMed

81.

Munoz M, Gomez-Ramirez S, Campos A, Ruiz J, Liumbruno GM. Pre-operative anaemia: prevalence, consequences and approaches to management. Blood Transfus. 2015;13:370–9.PubMedPubMedCentral

82.

von Heymann C, Kaufner L, Sander M, Spies C, Schmidt K, Gombotz H, et al. Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery? J Thorac Cardiovasc Surg. 2016;152:1412–20.

83.

Hogan M, Klein AA, Richards T. The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery. Eur J Cardiothorac Surg. 2015;47:218–26.PubMed

84.

Ho AM, Dion PW, Yeung JH, et al. Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology. 2012;116:716–28.PubMed

85.

Armand R, Hess JR. Treating coagulopathy in trauma patients. Transfus Med Rev. 2003;17:223–31.PubMed

86.

Kirchner C, Dirkmann D, Treckmann JW, Paul A, Hartmann M, Saner FH, et al. Coagulation management with factor concentrates in liver transplantation: a single-center experience. Transfusion. 2014;54:2760–8.PubMed

87.

Baumann Kreuziger LM, Morton CT, Subramanian AT, Anderson CP, Dries DJ. Not only in trauma patients: hospital-wide implementation of a massive transfusion protocol. Transfus Med. 2014;24:162–8.PubMed

88.

• Sommer N, Schnuriger B, Candinas D, Haltmeier T. Massive transfusion protocols in non-trauma patients: a systematic review and meta-analysis. J Trauma Acute Care Surg 2018;epub ahead. An interesting review and meta-analysis on the use of MTPs in non-trauma patients.

Titel: Transfusion Requirements in Anesthesia and Intensive Care
Publikationsdatum: 23.03.2019
Erschienen in: Current Anesthesiology Reports / Ausgabe 2/2019
Elektronische ISSN: 2167-6275
DOI: https://doi.org/10.1007/s40140-019-00320-5

Neu im Fachgebiet AINS

23.04.2024 | Appendizitis | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Transfusion Requirements in Anesthesia and Intensive Care

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Septic Shock and the Heart

How Does Frailty Affect ICU Outcome?

Pediatric Post-anesthesia Care Unit Challenges Update

Inotropes and Vasoactive Agents: Differences Between Europe and the United States

Pediatric Obstructive Sleep Apnea: Neurocognitive Consequences

Perioperative Oxygenation Targets in Adults

Neu im Fachgebiet AINS

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

S3-Leitlinie zu Pankreaskrebs aktualisiert

Update AINS